11
May

08:00 AM PDT

Oncology

Strategy Meeting West Coast USA 2022

The premier meeting for all West Coast USA Oncology professionals

The Westin St. Francis San Francisco on Union Square

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Oncology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Oncology professionals from across the West Coast, in San Francisco, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet Our 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Oncology strategy meeting.

Susan Weidner

Senior Vice President IntrinsiQ Analytics

Susan Weidner joined IntrinsiQ Specialty Solutions in 2013.  As the Senior Vice President, Susan is responsible for the Analytics business unit along with our community-based research network, AdvanceIQ Network, and our precision medicine strategies.  In her position, she also coordinates activities across both our software and analytics businesses in support of our specialty distribution and physician group purchasing organizations.
With over 20 years of healthcare experience, she has led the design, development and implementation of innovative healthcare solutions, including those driven by healthcare informatics.  Leveraging her expertise in clinical and outcomes research along with health economics, she has assisted pharmaceutical companies, payers and provider organizations in demonstrating the value of their product(s) and/or organizations.
Prior to joining IntrinsiQ Specialty Solutions, Susan held executive leadership positions at pharmaceutical, healthcare consulting, and precision medicine companies.

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Tatiana Eidus

Director Corporate Development North America, USA Arensia

Mike Reed, PhD

Chief Scientist, PhysioPD Rosa & Co.

Dr. Reed brings 15 years of experience managing large-scale strategic collaborations with client biopharmaceutical and consumer product organizations.
At Rosa (and previously at Entelos, Inc.), his areas of expertise include metabolic diseases, oncology, central nervous system diseases, and inflammation/immunology. His efforts focus on trial design, target evaluation, competitive differentiation, and novel biomarkers, and have led to several patents and publications. Dr. Reed’s work has been presented at dozens of scientific conferences worldwide.
Prior to his position at Entelos, Dr. Reed held positions in preclinical pharmacology and drug development at Shaman Pharmaceuticals Inc. and Tularik Inc. (acquired by Amgen Inc.). His contributions include the development of novel animal models for type 2 diabetes.
Dr. Reed completed his BS in Biology and MA in Exercise Physiology at The University of Texas at Austin, and a PhD in Exercise Physiology at The Ohio State University. He completed his postdoctoral fellowship at Stanford University, which focused on the mechanistic evaluation of insulin resistance in animal models.

Dan Norton

Associate Director, Product Management Personalis

Roman Hrynchuk

Chief Operating Officer Sanaclis

Gajanan Bhat

Vice President Clinical Sciences Spectrum Pharmaceuticals

Kun Chen

Senior Directio, Biostatistics, Oncology Gilead Sciences

Sashka Dimitrievska

Global Therapeutic Area Head Oncology Clinical Insights AstraZeneca

Ken Kobayashi

Senior Vice President Kinnate Biopharma

Anthony Maida III

Chief Clinical Officer Oncotellic Therapeutics

Dr. Maida is currently Chief Clinical Officer – Translational Medicine for Oncotelic, Inc. focused on the immunotherapy of cancer and infectious disease.  Formerly he was Senior Vice President – Clinical Research for Northwest Biotherapeutics, Inc., a cancer vaccine company focused on therapy of patients with glioblastoma multiforme and prostate cancer.  He is responsible for the oversight of the clinical and scientific operations of Oncotelic Therapeutics, Inc.  Dr. Maida was formerly Vice President of Clinical Research and General Manager, Oncology, World-wide for PharmaNet, Inc.  Prior to coming to Pharmanet Dr. Maida served as Chairman, Founder and Director of BioConsul Drug Development Corporation and Principal of Anthony Maida Consulting International, servicing pharmaceutical firms, venture capital, hedge funds and Wall Street, in the clinical development of therapeutic products and product/company acquisitions. For 30 years, Dr. Maida has focused on the clinical development of immunotherapies to treat patients with cancer.  Dr. Maida’s skill set includes the execution and oversight of finance, operations, research, and commercial clinical and scientific development, regulatory and manufacturing for the development of various therapeutic modalities.  Dr. Maida has served in a number of executive roles, including, Chairman, CEO, COO, CSO, CFO and business development.  Dr. Maida serves or has served on the advisory board of EndPoint BioCapital, Sdn Bhd (Kuala Lumpur, Malaysia), and as an advisor, consultant and technical analyst for CMX Capital, LLC, Sagamore Bioventures, Roaring Fork Capital, Toucan Capital, North Sound Capital, The Bonnie J. Addario Lung Cancer Foundation and Pediatric BioScience, Inc.  Additionally, Dr. Maida has been retained by Abraxis BioScience, Inc., Northwest BioTherapeutics, Inc. and Takeda Chemical Industries, Ltd. (Osaka, Japan). Dr. Maida sat on multiple public company boards and advisory committees.  Dr. Maida holds a B.A. degree in Biology, a B.A. Degree in History, a MBA, a MA in toxicology and a Ph.D. in Immunology.  He is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the Society of Neuro-Oncology (SNO), the International Society for Biological Therapy of Cancer (iSBTc) and the American Chemical Society.  Dr. Maida holds a number of patents and patent applications associated with various therapeutic modalities and approaches.

Mike Mattie

Director, Translational Sciences and External Collaborations Kite Pharma

John Rossi

Vice President Translational Medicine Cargo Therapeutics

Oscar Segurado

Chief Medical Officer ASC Therapeutics

Oscar Segurado is an executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and global medical affairs. C-suite executive and industry leader providing in-depth expertise for pre-clinical and clinical study strategy, planning, execution and monitoring, regulatory interactions, investor relations, fundraising, M&A and IPO process and deliverables. Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira). Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies. Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain.

Angus Sinclair

Vice President Oncology IGM Biosciences

Lixia Wang

Senior Vice President, Data Science & Informatics Atreca, Inc

David Zarling

Chief Executive Officer Colby Pharmaceuticals

Sanjay Khare

Senior Vice President Coherus BioSciences

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D San Francisco

Oncology

Strategy Meeting West Coast USA 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >The Westin St. Francis San Francisco on Union Square

Fresh Oncology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Meet Our 2022 Facilitators

Susan Weidner

Claudia Hesselmann, PhD

Tatiana Eidus

Mike Reed, PhD

Dan Norton

Roman Hrynchuk

Gajanan Bhat

Kun Chen

Sashka Dimitrievska

Ken Kobayashi

Anthony Maida III

Mike Mattie

John Rossi

Oscar Segurado

Angus Sinclair

Lixia Wang

David Zarling

Sanjay Khare

Our 2022 Thought Leader

Our 2022 Co-Hosts

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

The Westin St. Francis San Francisco on Union Square